Indaptus Therapeutics Inc (INDP) Live Share Price, Invest From India

Indaptus Therapeutics Inc Stock Performance

as on April 8, 2026 at 6:59 am IST

Day's Low
Day's High
$1.58
Day's Price Range
$1.86
$1.63
3.07%
Downside
14.11%
Upside
52 Week's Low
52 Week's High
$1.51
52-Week Price Range
$19.91
$1.63
7.36%
Downside
1121.69%
Upside

Indaptus Therapeutics Inc share price movements today

Previous Close: $1.75
Open: $1.86
Volume: 533.7K
Day's Low - High: $1.58 - $1.86
52 Week Low - High: $1.51 - $19.91

Indaptus Therapeutics Inc Historical Returns

1 Month Return: -5.41 %
3 Month Return: -34.94 %
1 Year Return: -86.84 %
3 Year Return: -96.39 %
5 Year Return: -89.66 %

Indaptus Therapeutics Inc Stock Fundamentals & Key Indicators

Check Indaptus Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.6M

EPS (TTM)

-6.43

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-19.8M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-587.59%

Indaptus Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Indaptus Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Indaptus Therapeutics Inc	BUY	$3.6M	-89.66%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$42.3B	134.83%	136.85	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$111.4B	104.17%	28.66	32.94%
Beone Medicines Ltd	NA	$35.7B	NA	126.85	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$80.5B	58.38%	18.38	31.41%

Stock Returns calculator for Indaptus Therapeutics Inc Stock including INR - Dollar returns

The Indaptus Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Indaptus Therapeutics Inc investment value today

Current value as on today

₹13,273

Returns

-₹86,727

(-86.73%)

Returns from Indaptus Therapeutics Inc Stock

-₹87,744 (-87.74%)

Dollar Impact

₹1,017 (+1.02%)

Analyst Recommendation on Indaptus Therapeutics Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Indaptus Therapeutics Inc. Average target price of $10

Indaptus Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Indaptus Therapeutics Inc.

What analysts predicted

83.7%UPSIDE

Target Price

$10

Current Price

$1.63

Analyzed by

8 Analysts

Target

$10.00

Indaptus Therapeutics Inc target price $10, a slight upside of 83.7% compared to current price of $1.63. According to 8 analysts rating.

Indaptus Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Indaptus Therapeutics Inc Stock has decreased by -62% in the last 30 days, reflecting a downward trend in search activity.

Time period: March 9, 2026 to April 8, 2026

Change:-62% versus previous 30 day period

Indaptus Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	0	-	-	-	0	-	-	-	-
Gross Profit	0	0	0	-	-	0	-	-	-	-
Operating Income	-4	-4	-3	-4	-3	-4	-4	-4	-2	-8
EBITDA	-4	-4	-3	-4	-3	-4	-4	-5	-2	-8
Interest Expense	-	0	-	-	-	-	-	-	-	-
Depreciation	0	0	0	-	-	-	-	-	-	-
Income Before Tax	-3	-4	-3	-4	-3	-4	-4	-5	-2	-8
Income Tax Expense	0	-4	0	-	-	0	-	-	-	-
Net Income	-3	-4	-3	-4	-3	-4	-4	-5	-2	-8
Net Profit Margin	0.00%	-207613.07%	0.00%	0.00%	0.00%	-281023.61%	0.00%	0.00%	0.00%	0.00%

Indaptus Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	-
Operating Income	-3	-7	-14	-16	-15	-19
EBITDA	-3	-7	-14	-16	-15	-19
Interest Expense	0	0	0	-	-	-
Depreciation	0	0	0	0	0	-
Income Before Tax	-3	-7	-14	-15	-15	-20
Income Tax Expense	0	0	0	-16	-	-
Net Income	-3	-7	-14	-15	-15	-20
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Indaptus Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-4	-3	-4	-3	-4	-4	-5	-2	-8
Operating Cash Flow	-2	-3	-2	-2	-3	-5	-4	-3	-3
Investing Cash Flow	0	-	-	-	-	-	-	-	-
Financing Cash Flow	-	0	0	2	1	3	6	2	5
Change in Cash	-2	-3	-2	0	-1	-1	2	0	2

Indaptus Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-28	-43	-47	-3	-7	-14	-15	-15	-20
Operating Cash Flow	-22	-39	-29	-3	-11	-13	-13	-12	-14
Investing Cash Flow	-4	-9	-3	0	0	-16	17	-	-
Financing Cash Flow	63	35	2	1	48	0	-	4	17
Change in Cash	36	-14	-29	-2	37	-29	3	-7	2

Global Institutional Holdings in Indaptus Therapeutics Inc

Funds	Holdings
UBS Group AG	0.02%
Morgan Stanley - Brokerage Accounts	0%
Bank of America Corp	0%
Investment House LLC	0%
Strategy Asset Managers LLC	0%

See all

Insights on Indaptus Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 56.6% return, outperforming this stock by 153.0%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 41.8% return, outperforming this stock by 128.6%
NEGATIVE IMPACT
Price Dip
In the last 7 days, INDP stock has moved down by -3.8%

About Indaptus Therapeutics Inc

the indaptus goal is simple: to cure disease with the ability to harness both the body’s innate and adaptive immune responses, we believe we are uniquely positioned to revolutionize the treatment of cancer and certain infectious diseases. building on the observation that tumor regression can occur in the setting of bacterial infection, we have developed a proprietary platform that exploits bacteria’s natural ability to activate both innate and adaptive cellular immune pathways. leveraging our novel insights into the levels and ratios of activating signals needed to safely elicit a broad immune response, we are creating and advancing a pipeline of proprietary, attenuated and killed non-pathogenic gram-negative bacterial candidates designed to be widely accessible, with broad anti-tumor and anti-viral activity.

Organisation	Indaptus Therapeutics Inc
Headquarters	Three Columbus Circle, New York, NY, United States, 10019
Industry	Healthcare
CEO	Mr. David Elliot Lazar
E-voting on shares	Click here to vote

Key Management of Indaptus Therapeutics Inc

Name	Title
Mr. David Elliot Lazar	Chairman & Co-CEO
Dr. Michael J. Newman Ph.D.	Founder, Chief Scientific Officer & Director
Mr. Walt Addison Linscott Esq.	Chief Operating Officer
Mr. Nir Sassi	CFO, Secretary & Treasurer

FAQs

What is Indaptus Therapeutics Inc share price today?

Indaptus Therapeutics Inc share price today is $1.63 as on April 8, 2026 at 1:29 am IST at the close of the market. Indaptus Therapeutics Inc share today touched a day high of $1.86 and a low of $1.58.

What is the 52 week high and 52 week low for Indaptus Therapeutics Inc share?

Indaptus Therapeutics Inc share touched a 52 week high of $19.91 on June 23, 2025 and a 52 week low of $1.51 on April 6, 2026. Indaptus Therapeutics Inc stock price today i.e. April 8, 2026 at 1:29 am IST is closed at $1.63,which is 91.81% down from its 52 week high and 7.95% up from its 52 week low.

What is Indaptus Therapeutics Inc's market capitalisation today?

Indaptus Therapeutics Inc market capitalisation is $0.00T as on April 8, 2026 at 1:29 am IST.

How to invest in Indaptus Therapeutics Inc Stock (INDP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Indaptus Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Indaptus Therapeutics Inc Shares that will get you 0.9202 shares as per Indaptus Therapeutics Inc share price of $1.63 per share as on April 8, 2026 at 1:29 am IST.

What is the minimum amount required to buy Indaptus Therapeutics Inc Stock (INDP) from India?

Indian investors can start investing in Indaptus Therapeutics Inc (INDP) shares with as little as ₹93.0075 or $1 (as of April 8, 2026 at 5:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹930.07 in Indaptus Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on April 8, 2026 at 5:39 am IST). Based on Indaptus Therapeutics Inc share’s latest price of $1.63 as on April 8, 2026 at 1:29 am IST, you will get 6.1350 shares of Indaptus Therapeutics Inc. Learn more about fractional shares .

What are the returns that Indaptus Therapeutics Inc has given to Indian investors in the last 5 years?

Indaptus Therapeutics Inc stock has given -89.66% share price returns and 25.14% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?